CoChat

A Systematic Review of Artificial Intelligence in Prostate Cancer

Open access
Van Booven, Derek J, Kuchakulla, Manish, Pai, Raghav, Frech, Fabio S, Ramasahayam, Reshna, Reddy, Pritika, Parmar, Madhumita, Ramasamy, Ranjith, Arora, Himanshu · 2021 · Research and Reports in Urology
Cited by 77

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The diagnosis and management of prostate cancer involves the interpretation of data from multiple modalities to aid in decision making. Tools like PSA levels, MRI guided biopsies, genomic biomarkers, and Gleason grading are used to diagnose, risk stratify, and then monitor patients during respective follow-ups. Nevertheless, diagnosis tracking and subsequent risk stratification often lend itself to significant subjectivity. Artificial intelligence (AI) can allow clinicians to recognize difficult relationships and manage enormous data sets, which is a task that is both extraordinarily difficult and time consuming for humans. By using AI algorithms and reducing the level of subjectivity, it is possible to use fewer resources while improving the overall efficiency and accuracy in prostate cancer diagnosis and management. Thus, this systematic review focuses on analyzing advancements in AI-based artificial neural networks (ANN) and their current role in prostate cancer diagnosis and management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/rru.s268596

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 41

  1. Torre, 2015, CA Cancer J Clin, 65, 87, 10.3322/caac.21262 · DOI · Paper page
  2. Harmon, 2019, Diagn Interv Radiol, 25, 183, 10.5152/dir.2019.19125 · DOI · Paper page
  3. Harmon, 2019, Diagn Interv Radiol, 25, 183, 10.5152/dir.2019.19125 · DOI · Paper page
  4. Carroll, 2018, J Natl Compr Canc Netw, 16, 620, 10.6004/jnccn.2018.0036 · DOI · Paper page
  5. Partin, 1994, J Urol, 152, 1358, 10.1016/S0022-5347(17)32422-9 · DOI · Paper page
  6. Catalona, 1991, N Engl J Med, 324, 1156, 10.1056/NEJM199104253241702 · DOI · Paper page
  7. Djavan, 2002, J Clin Oncol, 20, 921, 10.1200/JCO.2002.20.4.921 · doi:10.1200/jco.2002.20.4.921 · Paper page
  8. Stojadinovic, 2018, Srp Arh Celok Lek, 147, 39
  9. Finne, 2000, Urology, 56, 418, 10.1016/S0090-4295(00)00672-5 · DOI
  10. Ge P, Gao F, Chen G. Predictive models for prostate cancer based on logistic regression and artificial neural network. 2015 IEEE International Conference on Mechatronics and Automation (ICMA). 2015;1472–1477. · doi:10.1109/icma.2015.7237702
  11. Stephan, 2002, Clin Chem, 48, 1279, 10.1093/clinchem/48.8.1279 · DOI
  12. Humphrey, 2017, Cold Spring Harb Perspect Med, 7, a030411, 10.1101/cshperspect.a030411 · DOI · Paper page
  13. Waliszewski, 2015, Prostate, 75, 399, 10.1002/pros.22926 · DOI
  14. Lawrentschuk, 2011, Int Urol Nephrol, 43, 23, 10.1007/s11255-010-9750-7 · doi:10.1007/s11255-010-9750-7
  15. Rodvold, 2001, Prostate, 46, 39, 10.1002/1097-0045(200101)46:1<39::AID-PROS1006>3.0.CO;2-M · DOI · Paper page
  16. Remzi, 2003, Urology, 62, 456, 10.1016/S0090-4295(03)00409-6 · DOI
  17. Moore, 2014, Curr Opin Urol, 24, 280, 10.1097/MOU.0000000000000040 · doi:10.1097/mou.0000000000000040
  18. Sato, 2005, J Magn Reson Imaging, 21, 258, 10.1002/jmri.20251 · DOI · Paper page
  19. Fehr, 2015, Proc Natl Acad Sci U S A, 112, E6265, 10.1073/pnas.1505935112 · DOI · Paper page
  20. Antonelli, 2019, Eur Radiol, 29, 4754, 10.1007/s00330-019-06244-2 · DOI
  21. Toivonen, 2019, PLoS One, 14, e0217702, 10.1371/journal.pone.0217702 · DOI
  22. Choyke, 2017, Oncology (Williston Park), 31, 67
  23. Jin, 2020, Mediators Inflamm, 2020, 8730608, 10.1155/2020/8730608 · doi:10.1155/2020/8730608
  24. McDonald, 2018, Prostate, 78, 411, 10.1002/pros.23485 · doi:10.1002/pros.23485
  25. Martignano, 2017, Clin Chim Acta, 473, 96, 10.1016/j.cca.2017.08.009 · DOI
  26. Jakobsen, 2016, J Clin Urol, 9, 3, 10.1177/2051415816656121 · DOI
  27. Filella, 2016, Int J Mol Sci, 17, 10.3390/ijms17111784 · DOI
  28. Reed, 2010, Expert Rev Anticancer Ther, 10, 103, 10.1586/era.09.168 · DOI
  29. Margreiter, 2008, Minerva Urol Nefrol, 60, 51
  30. Parekh, 2007, J Urol, 178, 2252, 10.1016/j.juro.2007.08.055 · DOI
  31. Shariat, 2007, Future Oncol, 3, 449, 10.2217/14796694.3.4.449 · DOI
  32. Stephan, 2007, Cancer Lett, 249, 18, 10.1016/j.canlet.2006.12.031 · doi:10.1016/j.canlet.2006.12.031
  33. Fruge, 2020, Front Oncol, 10, 544201, 10.3389/fonc.2020.544201 · DOI
  34. Green, 2016, Br J Cancer, 115, 236, 10.1038/bjc.2016.169 · DOI
  35. Kim, 2016, Nat Commun, 7, 11906, 10.1038/ncomms11906 · DOI · Paper page
  36. Auffenberg, 2019, Eur Urol, 75, 901, 10.1016/j.eururo.2018.09.050 · DOI
  37. Alitto, 2017, Future Oncol, 13, 2171, 10.2217/fon-2017-0142 · DOI
  38. Neeraj, 2017, Proc SPIE
  39. Naguib, 1998, Br J Cancer, 78, 246, 10.1038/bjc.1998.472 · DOI
  40. Gustavsen, 2020, Future Oncol, 16, 4265, 10.2217/fon-2019-0639 · DOI
  41. Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology. 2009;62:(10). · DOI · Paper page

Cited by

See all 77

Metadata

Authors
Van Booven, D. J., Kuchakulla, M., Pai, R., Frech, F. S., Ramasahayam, R., Reddy, P., Parmar, M., Ramasamy, R., & Arora, H.
Venue
Research and Reports in Urology
Published
2021-01
Volume
Volume 13
Pages
31-39
ISSN
  • 1179-1551 (ISSN-L)
  • 2253-2447
OpenAlex
W3122808534
Cited by
77
References
1
FWCI
1.36
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.